AU1404395A - Anti-mullerian hormone receptor polypeptides and antibodies thereto - Google Patents
Anti-mullerian hormone receptor polypeptides and antibodies theretoInfo
- Publication number
- AU1404395A AU1404395A AU14043/95A AU1404395A AU1404395A AU 1404395 A AU1404395 A AU 1404395A AU 14043/95 A AU14043/95 A AU 14043/95A AU 1404395 A AU1404395 A AU 1404395A AU 1404395 A AU1404395 A AU 1404395A
- Authority
- AU
- Australia
- Prior art keywords
- antibodies
- hormone receptor
- receptor polypeptides
- mullerian hormone
- mullerian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108010005853 Anti-Mullerian Hormone Proteins 0.000 title 1
- 102100030173 Muellerian-inhibiting factor Human genes 0.000 title 1
- 239000000868 anti-mullerian hormone Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 108020003175 receptors Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US166333 | 1980-07-07 | ||
| US16633393A | 1993-12-13 | 1993-12-13 | |
| US17351293A | 1993-12-23 | 1993-12-23 | |
| US173512 | 1993-12-23 | ||
| PCT/US1994/014643 WO1995016709A2 (en) | 1993-12-13 | 1994-12-13 | Anti-mullerian hormone receptor polypeptides and antibodies thereto |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1404395A true AU1404395A (en) | 1995-07-03 |
Family
ID=26862184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU14043/95A Abandoned AU1404395A (en) | 1993-12-13 | 1994-12-13 | Anti-mullerian hormone receptor polypeptides and antibodies thereto |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1404395A (en) |
| WO (1) | WO1995016709A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6677135B1 (en) | 1996-05-08 | 2004-01-13 | Biogen, Inc. | Ret ligand (RetL) for stimulating neutral and renal growth |
| CA2253871C (en) * | 1996-05-08 | 2005-04-26 | Biogen, Inc. | Ret ligand (retl) for stimulating neural and renal growth |
| US6673352B1 (en) | 1999-09-14 | 2004-01-06 | The General Hospital Corporation | Use of Mullerian inhibiting substance for treating excess androgen states |
| WO2005005615A2 (en) | 2003-07-08 | 2005-01-20 | Fox Chase Cancer Center | Anti-mullerian inhibiting substance type ii receptor (misiir) immunoconjugates to detect and treat cancer |
| ATE430763T1 (en) | 2004-03-30 | 2009-05-15 | Nsgene As | THERAPEUTIC USE OF GROWTH FACTOR NSG33 |
| WO2011045202A1 (en) | 2009-10-12 | 2011-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Selective antagonist or agonist of amhrii for modulating fertility |
| ITRM20130455A1 (en) * | 2013-08-05 | 2015-02-06 | Alfonso Baldi | LIGANDI DELL'ORMONE ANTI-MULLERIANO |
| ES2675040T3 (en) | 2014-02-03 | 2018-07-05 | Inserm - Institut National De La Santé Et De La Recherche Médicale | Soluble monomeric fusion proteins of the type II receptor of the antimullerian hormone and uses thereof |
| AU2015320341B2 (en) * | 2014-09-26 | 2021-05-27 | Rajendra Sahai Bhatnagar | Inhibitors of NF kappa-B activity for treatment of diseases and disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3920693A (en) * | 1992-03-18 | 1993-10-21 | General Hospital Corporation, The | Four novel receptors of the TGF-beta receptor family |
-
1994
- 1994-12-13 WO PCT/US1994/014643 patent/WO1995016709A2/en not_active Ceased
- 1994-12-13 AU AU14043/95A patent/AU1404395A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995016709A3 (en) | 1995-08-10 |
| WO1995016709A2 (en) | 1995-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1183295A (en) | Immunoassays employing generic anti-hapten antibodies and materials for use therein | |
| AU4855393A (en) | Polypeptides of g-coupled receptor proteins, and compositions and methods thereof | |
| AU3764593A (en) | CCK and/or gastrin receptor ligands | |
| IL109159A (en) | Immunoassays for tetrachloroiso-phthalonitrile and its metabolites and antibodies for use therein | |
| GR3033095T3 (en) | Anti-gp39 antibodies and uses therefor | |
| AU5927398A (en) | Fc receptors and polypeptides | |
| EP0613007A3 (en) | Pharmaceutical screens and antibodies. | |
| PL314908A1 (en) | Humanised antibodies and their application | |
| ZA973247B (en) | Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor. | |
| AU6310690A (en) | Immunoassay device and materials | |
| AU5165193A (en) | Human steroid hormone receptor neri | |
| AU7576096A (en) | Il-13 receptor polypeptide | |
| EP0634019A4 (en) | Immunoassays employing generic anti-hapten antibodies and materials for use therein. | |
| AU5611394A (en) | Antibodies for gm-csf receptor and uses thereof | |
| GB9009549D0 (en) | Recombinant antibody and method | |
| AU2020497A (en) | Receptor and transporter antagonists | |
| HU9503067D0 (en) | Endotheline receptor antagonists | |
| IL124808A0 (en) | Assay for and uses of peptide hormone receptor ligands | |
| AU635996B2 (en) | Recombinant human anti-cd18 antibodies | |
| AU7257391A (en) | Recombinant thyrotropin receptor | |
| AU2097592A (en) | Fibrinogen-specific monoclonal antibody and uses thereof | |
| AU1404395A (en) | Anti-mullerian hormone receptor polypeptides and antibodies thereto | |
| AU6750594A (en) | Receptors of interleukin-12 and antibodies | |
| AU4950393A (en) | Dna sequence encoding a novel member of the steroid and thyroid hormone receptor family | |
| AU6596096A (en) | Calcitonin gene-related peptide receptor component factor (houdc44) |